Factors Affecting the Diagnostic Discordance Between Frozen and Permanent Sections in Mucinous Ovarian Tumors

References

• Purwoto G, Anggraeni TD, Rustamadji P, Surya IU, Julianti K, Herlambang N. Histopathological discrepancy and variation of surgical management in mucinous ovarian cystadenoma and pseudomyxoma peritonei. Int J Surg Case Rep. 2022;94:107141. doi:10.1016/j.ijscr.2022.107141
   PubMed Web of Science ®Google Scholar
• Moon AS, DeAngelis AM, Fairbairn M, et al. Removal of 132-pound ovarian mucinous cystadenoma: a case report. SAGE Open Med Case Rep. 2020;8:2050313X2090673. doi:10.1177/2050313X20906738
   Web of Science ®Google Scholar
• Frumovitz M, Schmeler KM, Malpica A, Sood AK, Gershenson DM. Unmasking the complexities of mucinous ovarian carcinoma. Gynecologic Oncol. 2010;117(3):491–496. doi:10.1016/j.ygyno.2010.02.010
   PubMed Web of Science ®Google Scholar
• Hart WR. Mucinous tumors of the ovary: a review. Int J Gynecol Pathol. 2005;24(1):4–25.
   PubMed Web of Science ®Google Scholar
• Koensgen D, Weiss M, Assmann K, et al. Characterization and management of borderline ovarian tumors - results of a retrospective, single-center study of patients treated at the department of gynecology and obstetrics of the University Medicine Greifswald. Anticancer Res. 2018;38(3):1539–1545. doi:10.21873/anticanres.12382
   PubMed Web of Science ®Google Scholar
• Khunamornpong S, Settakorn J, Sukpan K, Suprasert P, Siriaunkgul S. Mucinous tumor of low malignant potential (“borderline” or “atypical proliferative” tumor) of the ovary: a study of 171 cases with the assessment of intraepithelial carcinoma and microinvasion. Int J Gynecol Pathol. 2011;30(3):218–230. doi:10.1097/PGP.0b013e3181fcf01a
   PubMed Web of Science ®Google Scholar
• Koskas M, Uzan C, Gouy S, et al. Prognostic factors of a large retrospective series of mucinous borderline tumors of the ovary (Excluding Peritoneal Pseudomyxoma). Ann Surg Oncol. 2011;18(1):40–48. doi:10.1245/s10434-010-1293-8
   PubMed Web of Science ®Google Scholar
• Colombo N, Sessa C, du Bois A, et al. ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease†. Ann Oncol. 2019;30(5):672–705. doi:10.1093/annonc/mdz062
   PubMed Web of Science ®Google Scholar
• Cadron I, Leunen K, Van Gorp T, Amant F, Neven P, Vergote I. Management of borderline ovarian neoplasms. JCO. 2007;25(20):2928–2937. doi:10.1200/JCO.2007.10.8076
   PubMed Web of Science ®Google Scholar
• Franchi D, Boveri S, Radice D, et al. Ultrasonographic diagnosis and longitudinal follow-up of recurrences after conservative surgery for borderline ovarian tumors. Am J Obstet Gynecol. 2016;215(6):756.e1–756.e9. doi:10.1016/j.ajog.2016.07.024
   PubMed Web of Science ®Google Scholar
• Nishio N, Kido A, Kataoka M, et al. Longitudinal changes in magnetic resonance imaging of malignant and borderline tumors associated with ovarian endometriotic cyst comparing with endometriotic cysts without arising malignancy. Eur J Radiol. 2018;105:175–181. doi:10.1016/j.ejrad.2018.06.007
   PubMed Web of Science ®Google Scholar
• Huang Y, Xu J, Li K, Wang J, Dai Y, Kang Y. A novel, personalized drug-screening system for platinum-resistant ovarian cancer patients: a preliminary clinical report. Cancer Manag Res. 2021;13:2849–2867. doi:10.2147/CMAR.S276799
   PubMed Web of Science ®Google Scholar
• Kyung MS. Serum CA19-9 as a predictor of malignancy in primary ovarian mucinous tumors: a matched case-control study. Med Sci Monit. 2014;20:1334–1339. doi:10.12659/MSM.890954
   PubMed Web of Science ®Google Scholar
• Zhang T, Pang A, Lyu J, et al. Application of nonlinear models combined with conventional laboratory indicators for the diagnosis and differential diagnosis of ovarian cancer. J Clin Med. 2023;12(3):844. doi:10.3390/jcm12030844
   PubMed Web of Science ®Google Scholar
• Sánchez Vega JF, Murillo Bacilio M, Vintimilla Condoy AS, Palta González AM, Crespo Astudillo JA, Mora-Bravo FG. Predictive equation of metastasis in patients with malignant ovarian epithelial tumors with the Ca-125 marker. BMC Cancer. 2018;18(1):587. doi:10.1186/s12885-018-4499-y
   PubMedGoogle Scholar
• Varras M. Benefits and limitations of ultrasonographic evaluation of uterine adnexal lesions in early detection of ovarian cancer. Clin Exp Obstet Gynecol. 2004;31(2):85–98.
   PubMedGoogle Scholar
• Necula L, Matei L, Dragu D, et al. Collagen family as promising biomarkers and therapeutic targets in cancer. Int J Mol Sci. 2022;23(20):12415. doi:10.3390/ijms232012415
   PubMed Web of Science ®Google Scholar
• Wakahara F, Kikkawa F, Nawa A, et al. Diagnostic efficacy of tumor markers, sonography, and intraoperative frozen section for ovarian tumors. Gynecol Obstet Invest. 2001;52(3):147–152. doi:10.1159/000052963
   PubMed Web of Science ®Google Scholar
• Maheshwari A, Gupta S, Kane S, Kulkarni Y, Goyal BK, Tongaonkar HB. Accuracy of intraoperative frozen section in the diagnosis of ovarian neoplasms: experience at a tertiary oncology center. World J Surg Oncol. 2006;4(1):12. doi:10.1186/1477-7819-4-12
   PubMedGoogle Scholar
• Huang J, Zhou H, Tan C, Mo S, Liu T, Kuang Y. The overexpression of actin related protein 2/3 complex subunit 1B(ARPC1B) promotes the ovarian cancer progression via activation of the Wnt/β-catenin signaling pathway. Front Immunol. 2023;14:1182677. doi:10.3389/fimmu.2023.1182677
   PubMed Web of Science ®Google Scholar
• Armstrong DK, Alvarez RD, Bakkum-Gamez JN, et al. Ovarian cancer, version 2.2020, NCCN clinical practice guidelines in oncology. J National Compr Cancer Network. 2021;19(2):191–226. doi:10.6004/jnccn.2021.0007
   PubMed Web of Science ®Google Scholar
• Gershenson DM. Management of borderline ovarian tumours. Best Pract Res Clin Obstet Gynaecol. 2017;41:49–59. doi:10.1016/j.bpobgyn.2016.09.012
   PubMed Web of Science ®Google Scholar
• Berek JS, Kehoe ST, Kumar L, Friedlander M. Cancer of the ovary, fallopian tube, and peritoneum. Intl J Gynecology & Obste. 2018;143(S2):59–78. doi:10.1002/ijgo.12614
   PubMedGoogle Scholar
• Gulzar R, Shahid R, Mumtaz S, Hassan JA. Significance of peritoneal washing cytology in the accurate staging of malignant ovarian tumors. Pak J Med Sci. 2022;38(1):128–132. doi:10.12669/pjms.38.1.4393
   PubMed Web of Science ®Google Scholar
• Vasconcelos I, De Sousa Mendes M. Conservative surgery in ovarian borderline tumours: a meta-analysis with emphasis on recurrence risk. Eur J Cancer. 2015;51(5):620–631. doi:10.1016/j.ejca.2015.01.004
   PubMed Web of Science ®Google Scholar
• Kim JH, Ha HI, Kim MH, Han MR, Park SY, Lim MC. A modified intraperitoneal chemotherapy regimen for ovarian cancer: technique and treatment outcomes. Cancers. 2021;13(19):4886. doi:10.3390/cancers13194886
   PubMed Web of Science ®Google Scholar
• Palakkan S, Augestine T, Valsan M, Vahab KA, Nair L. Role of frozen section in surgical management of ovarian neoplasm. Gynecol Minim Invasive Ther. 2020;9(1):13. doi:10.4103/GMIT.GMIT_2_19
   PubMed Web of Science ®Google Scholar
• Stewart CJR, Brennan BA, Hammond IG, Leung YC, McCartney AJ. Intraoperative assessment of ovarian tumors: a 5-year review with assessment of discrepant diagnostic cases. Int J Gynecol Pathol. 2006;25(3):216–222. doi:10.1097/01.pgp.0000215295.45738.ed
   PubMed Web of Science ®Google Scholar
• Gol M, Baloglu A, Yigit S, Dogan M, Aydin C, Yensel U. Accuracy of frozen section diagnosis in ovarian tumors: is there a change in the course of time? Int J Gynecol Cancer. 2003;13(5):593–597. doi:10.1136/ijgc-00009577-200309000-00004
   PubMed Web of Science ®Google Scholar
• Huang Z, Li L, Li C, et al. Diagnostic accuracy of frozen section analysis of borderline ovarian tumors: a meta-analysis with emphasis on misdiagnosis factors. J Cancer. 2018;9(16):2817–2824. doi:10.7150/jca.25883
   PubMed Web of Science ®Google Scholar
• Karataşlı V, Can B, Çakır İ, et al. Effect of tumor size on the accuracy of frozen section in the evaluation of mucinous borderline ovarian tumors. J Gynecol Obstet Hum Reprod. 2020;49(6):101765. doi:10.1016/j.jogoh.2020.101765
   PubMed Web of Science ®Google Scholar
• Basaran D, Salman MC, Boyraz G, et al. Accuracy of intraoperative frozen section in the evaluation of patients with adnexal mass: retrospective analysis of 748 cases with multivariate regression analysis. Pathol Oncol Res. 2015;21(1):113–118. doi:10.1007/s12253-014-9795-5
   PubMed Web of Science ®Google Scholar
• Moroney MR, Post MD, Berning AA, Sheeder J, Corr BR. An evaluation of frozen section and lymph node dissection results for mucinous ovarian tumors. Int J Gynecol Cancer. 2018;28(1):92–98. doi:10.1097/IGC.0000000000001150
   PubMed Web of Science ®Google Scholar
• Park JY, Lee SH, Kim KR, Kim YT, Nam JH. Accuracy of frozen section diagnosis and factors associated with final pathological diagnosis upgrade of mucinous ovarian tumors. J Gynecol Oncol. 2019;30(6):e95. doi:10.3802/jgo.2019.30.e95
   PubMed Web of Science ®Google Scholar
• Pongsuvareeyakul T, Khunamornpong S, Settakorn J, Sukpan K, Suprasert P, Siriaunkgul S. Accuracy of frozen-section diagnosis of ovarian mucinous tumors. Int J Gynecol Cancer. 2012;22(3):400–406. doi:10.1097/IGC.0b013e31823dc328
   PubMed Web of Science ®Google Scholar
• Zhang W, Jia S, Xiang Y, Yang J, Jia C, Leng J. Factors associated with misdiagnosis of frozen section of mucinous borderline ovarian tumor. J Int Med Res. 2019;47(1):96–104. doi:10.1177/0300060518795582
   PubMed Web of Science ®Google Scholar
• Jiang X, Yang J, Yu M, et al. Oncofertility in patients with stage I epithelial ovarian cancer: fertility-sparing surgery in young women of reproductive age. World J Surg Oncol. 2017;15:154. doi:10.1186/s12957-017-1222-4
   PubMed Web of Science ®Google Scholar
• Groen RS, Gershenson DM, Fader AN. Updates and emerging therapies for rare epithelial ovarian cancers: one size no longer fits all. Gynecologic Oncol. 2015;136(2):373–383. doi:10.1016/j.ygyno.2014.11.078
   PubMed Web of Science ®Google Scholar
• Gadducci A, Tana R, Landoni F, et al. Analysis of failures and clinical outcome of advanced epithelial ovarian cancer in patients with microscopic residual disease at second-look reassessment following primary cytoreductive surgery and first-line platinum-based chemotherapy. Eur J Gynaecol Oncol. 2013;34(3):213–217.
   PubMed Web of Science ®Google Scholar
• Ureyen I, Turan T, Cirik DA, et al. Frozen section in borderline ovarian tumors: is it reliable? Eur J Obstetrics Gynecol Reprod Biol. 2014;181:115–118. doi:10.1016/j.ejogrb.2014.07.039
   PubMed Web of Science ®Google Scholar
• Tempfer CB, Polterauer S, Bentz EK, Reinthaller A, Hefler LA. Accuracy of intraoperative frozen section analysis in borderline tumors of the ovary: a retrospective analysis of 96 cases and review of the literature. Gynecol Oncol. 2007;107(2):248–252. doi:10.1016/j.ygyno.2007.06.008
   PubMed Web of Science ®Google Scholar